| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4423185f79003e8f9b981e29323454a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-20 |
| filingDate |
2021-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6886d7410714bea33e08a1735b843724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ccc85b6e38501b5d36092e9859b96f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7f1c6f4800d1dce83b9b62a0e1d9bee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e08655ee09294515d46f5bb9712b48e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dd462540c87d06e277865f8fe376161 |
| publicationDate |
2021-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021222673-A1 |
| titleOfInvention |
Processes for the preparation of a kinase inhibitor |
| abstract |
The present invention relates to processes for the synthetic preparation of c-Met inhibitors of Formula I, or pharmaceutically acceptable salts thereof. The present invention further relates to processes for the synthetic preparation of the c-Met inhibitor, Compound 1, or a pharmaceutically acceptable salt thereof. The present invention also relates to processes for the synthetic preparation of Compound 1·hemifumarate. The invention further relates to large scale processes for the synthetic preparation of the c-Met inhibitor, Compound 1 and Compound 1·hemifumarate. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11542259-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023081253-A1 |
| priorityDate |
2020-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |